Related references
Note: Only part of the references are listed.Low penetrance of antibiotics in the epithelial lining fluid. The role of inhaled antibiotics in patients with bronchiectasis
Theodoros Karampitsakos et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2020)
Risk factors for ventilator -associated pneumonia following cardiac surgery
N. Hassoun-Kheir et al.
JOURNAL OF HOSPITAL INFECTION (2020)
What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review
Chandra Datta Sumi et al.
CLINICAL PHARMACOKINETICS (2019)
Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Joshua P. Metlay et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults
Tobias Welte et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Summary of the safety and tolerability of two treatment regimens of ceftaroline fosamil: 600mg every 8h versus 600mg every 12h
Karen Cheng et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drain
Alexia Chauzy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Ceftaroline fosamil doses and b breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections
Shampa Das et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators
Andrew Cristinacce et al.
INFECTIOUS DISEASES AND THERAPY (2019)
Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients
Sofie A. M. Dhaese et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis
Giovanni Sotgiu et al.
RESPIRATORY RESEARCH (2018)
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Antoni Torres et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Dosing antibiotic prophylaxis during cardiopulmonary bypass-a higher level of complexity? A structured review
Fathima Paruk et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Pneumonia after cardiac surgery: Experience of the National Institutes of Health/Canadian Institutes of Health Research Cardiothoracic Surgical Trials Network
Gorav Ailawadi et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2017)
Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic Review
Reese A. Cosimi et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application
Juwon Yim et al.
INFECTIOUS DISEASES AND THERAPY (2017)
Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials
Maria Taboada et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Penetration of Ceftaroline into the Epithelial Lining Fluid of Healthy Adult Subjects
Todd A. Riccobene et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Single- and Repeated-Dose Pharmacokinetics of Ceftaroline in Plasma and Soft Tissues of Healthy Volunteers for Two Different Dosing Regimens of Ceftaroline Fosamil
Peter Matzneller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
Mohd H. Abdul-Aziz et al.
INTENSIVE CARE MEDICINE (2016)
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities
Matthew Dryden et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery
Christian Lanckohr et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2016)
A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis
Joel M. Dulhunty et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Sources of Variation in Hospital-Level Infection Rates After Coronary Artery Bypass Grafting: An Analysis of The Society of Thoracic Surgeons Adult Heart Surgery Database
Donald S. Likosky et al.
ANNALS OF THORACIC SURGERY (2015)
Pharmacokinetics of Ceftaroline in Normal Body Weight and Obese (Classes I, II, and III) Healthy Adult Subjects
Julie Ann Justo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
A Critical Review on the Clinical Pharmacokinetics, Pharmacodynamics, and Clinical Trials of Ceftaroline
Tony K. L. Kiang et al.
CLINICAL PHARMACOKINETICS (2015)
Evaluation of the pharmacokinetics and safety of single and multiple ceftaroline fosamil infusions in healthy Chinese and Western subjects
Li Yang et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
Christy Maggiore et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2015)
Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting
Martin Andreas et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2015)
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2014)
Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial
Jan J. De Waele et al.
INTENSIVE CARE MEDICINE (2014)
An international, multicentre survey of -lactam antibiotic therapeutic drug monitoring practice in intensive care units
Gloria Wong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Management Practices and Major Infections After Cardiac Surgery
Annetine C. Gelijns et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Ventilator-associated pneumonia after cardiac surgery: A meta-analysis and systematic review
Siyi He et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2014)
Internal Mammary Artery Harvesting Influences Antibiotic Penetration Into Presternal Tissue
Martin Andreas et al.
ANNALS OF THORACIC SURGERY (2013)
Single- and Multiple-Dose Study To Determine the Safety, Tolerability, and Pharmacokinetics of Ceftaroline Fosamil in Combination with Avibactam in Healthy Subjects
Todd A. Riccobene et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Efficacy of Ceftaroline Fosamil in a Staphylococcal Murine Pneumonia Model
Amira A. Bhalodi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Therapeutic drug monitoring of antimicrobials
Jason A. Roberts et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Ventilator-associated pneumonia is an important risk factor for mortality after major cardiac surgery
Eduardo Tamayo et al.
JOURNAL OF CRITICAL CARE (2012)
Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
Fekade Bruck Sime et al.
ANNALS OF INTENSIVE CARE (2012)
Ceftaroline: a comprehensive update
Darpan Kaushik et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia
Douglas R. Rank et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia
Donald E. Low et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia
Thomas M. File et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Recent advances in clinical microdialysis
Peter Matzneller et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2011)
Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double-Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin-Structure Infection
G. Ralph Corey et al.
CLINICAL INFECTIOUS DISEASES (2010)
Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
Mark H. Wilcox et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
G. Ralph Corey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Antibiotic resistance - What's dosing got to do with it?
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2008)
Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy
Julia Langgartner et al.
INTENSIVE CARE MEDICINE (2008)
AAPS-FDA workshop white paper:: Microdialysis principles, application and regulatory perspectives
Chandra S. Chaurasia et al.
PHARMACEUTICAL RESEARCH (2007)
Lung microdialysis - A powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review)
M Zeitlinger et al.
AAPS JOURNAL (2005)
Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem
JL Kuti et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Pharmacodynamics of cefepime in patients with Gram-negative infections
VH Tam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Surgery and intensive care procedures affect the target site distribution of piperacillin
M Brunner et al.
CRITICAL CARE MEDICINE (2000)
Share Paper
